Výsledky vyhledávání - "Cathrina Karup"

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

Autor: Serge Jabbour, Cathrina Karup, Jochen Seufert, André Scheen, Clifford J. Bailey, Anna Maria Langkilde

Publikováno v: Diabetes, Obesity & Metabolism

Aim To evaluate the safety and tolerability of dapagliflozin, a highly selective sodium‐glucose co‐transporter‐2 inhibitor, in patients with type 2 diabetes mellitus (T2DM). Methods Data were pooled from 13 placebo‐controlled trials of up to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::130a86f78ba55d8fd9b709e0743c228b
https://pubmed.ncbi.nlm.nih.gov/28950419

Zobrazit plný text záznamu

Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonists

Autor: Neal D. Shore, Kurt Miller, Laurence Klotz, Anders Malmberg, Bo-Eric Persson, E. David Crawford, Cathrina Karup, Bertrand Tombal

Publikováno v: European urology. 66(6)

BACKGROUND: Studies comparing the gonadotropin-releasing hormone antagonist, degarelix, with luteinising hormone-releasing hormone (LHRH) agonists indicate differences in outcomes. OBJECTIVE: To assess differences in efficacy and safety outcomes in a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::895273c6c1f87bfeba3a1846df7bdb49
https://pubmed.ncbi.nlm.nih.gov/26149730

Zobrazit plný text záznamu

716 ANALYSIS OF DISEASE CONTROL-RELATED OUTCOMES FROM SIX COMPARATIVE RANDOMISED CLINICAL TRIALS OF DEGARELIX VERSUS LUTEINISING HORMONE-RELEASING HORMONE AGONISTS

Autor: Cathrina Karup, Kurt Miller, Bo-Eric Persson, Egbert van der Meulen, Neal D. Shore, Bertrand Tombal, E. David Crawford

Publikováno v: Journal of Urology. 189

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::99b013b5c143409b6c73ce54d13f3c67
https://doi.org/10.1016/j.juro.2013.02.275

Zobrazit plný text záznamu

Hot flushes in prostatic cancer patients during androgen deprivation therapy with monthly degarelix or leuprolide

Autor: Peter Iversen, I Huhtaniemi, E. Van Der Meulen, László B. Tankó, Cathrina Karup

Publikováno v: Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases, Nature Publishing Group, 2011, ⟨10.1038/pcan.2011.11⟩

The aim of the study was to compare the onset, incidence and frequency/intensity of hot flushes during androgen-deprivation therapy with a gonadotropin-releasing hormone antagonist (GnRH) blocker versus an agonist using data from a randomized Phase 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a1dac2e7d3e98dd45742468c6503fd
https://hal.archives-ouvertes.fr/hal-00627535/file/PEER_stage2_10.1038%2Fpcan.2011.11.pdf